Overview
The Journal of Hematopathology provides pathologists interested in hematopathology with information needed to perform high-quality diagnostic pathology of hematopoietic and lymphoid disease in lymphoid tissues, bone marrow and peripheral blood. The journal also benefits hematologists, molecular biologists and researchers of lymphomas, leukemia and other hematopoietic and lymphoid diseases.
- Editor-in-Chief
-
- Nathanael Bailey
- Impact factor
- 0.6 (2022)
- 5 year impact factor
- 0.6 (2022)
- Submission to first decision (median)
- 14 days
- Downloads
- 251,900 (2023)
Latest articles
Journal updates
-
Call for Papers - Diffuse large B-cell lymphoma and variants Collection
The Journal of Hematopathology is delighted to invite you to submit your papers to be part of its new collection. Click through for more information and submit today. We look forward to reading your work.
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Journal information
- Electronic ISSN
- 1865-5785
- Print ISSN
- 1868-9256
- Abstracted and indexed in
-
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- Dimensions
- EBSCO
- EMBASE
- EMCare
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Portico
- ProQuest
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information